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Background: Epstein-Barr virus associated gastric lymphoe-
pithelioma-like carcinoma (LELC) is characterized by the in-
tensive infiltration of lymphoid cells, the presence of EBV, 
and the better prognosis over typical adenocarcinoma. Thus, 
it was assumable that viral latent proteins may be respon-
sible for the recruitment of a certain T cell repertoire to 
EBV-associated gastric carcinoma. Methods: To examine 
above possibility, EBV gene expression in gastric carcinoma 
tissues and usage of TCR among the tumor infiltrating lym-
phocytes were analyzed. Results: EBV specific DNA and 
EBERs RNA were detected in 4 out of 30 patients. RT-PCR 
analysis revealed that all 4 of EBV-positive tumor tissues ex-
pressed EBNA1 mRNA and BARTs and LMP2a was detected 
only one sample out of 4. However, the EBNA2 and LMP-1 
transcripts were not detected in these tissues. CD8
＋ T cells 
were the predominant population of infiltrating lymphocytes 
in the EBV-positive gastric carcinoma. According to spectra 
type analysis of infiltrating T cells, 10 predominant bands 
were detected by TCR Vβ CDR3 specific RT-PCR from 4 
EBV-positive tumor tissues. Sequence analysis of these 
bands revealed oligoclonal expansion of T cells. Conclusion: 
These findings suggest that clonally expanded T cells in vivo 
might be a population of cytotoxic T cells reactive to EBV-as-
sociated gastric carcinoma.
[Immune Network 2011;11(1):50-58]
INTRODUCTION
Epstein-Barr virus (EBV) is a DNA virus that belongs to the 
Herpesviridae family and infects more than 90% of the entire 
world population. EBV causes infectious mononucleosis, and 
is related to lymphocyte and epithelial cell origin tumors such 
as  Burkitt’s  lymphoma,  lymphomas  associated  with  im-
munocompromised  patients,  and  undifferentiated  nasophar-
yngeal  carcinoma  (NPC).  EBV  persists  asymptomatically  in 
l i f e l o n g  c a r r i e r s  d u e  t o  a  b a l a n c e  b e t w e e n  i t s  c a p a b i l i t y  t o  
transform B cells into proliferating lymphoblasts and a tight 
control of EBV
＋ B cells mainly by CD8
＋ T cells (1). Different 
forms of EBV latency are recognized, and these are defined 
by the extent of latent viral gene expression. On initial EBV 
infection, and in latently infected lymphoblastoid cell lines in 
culture, the full spectrum of EBV latency genes, EBV nuclear 
antigen  1  (EBNA1),  EBNA2,  EBNA3A,  EBNA3B,  EBNA3C, 
EBNA-LP,  latent  membrane  protein  1  (LMP-1),  LMP-2A, 
LMP-2B, and BamHI A rightward transcripts (BARTs), is ex-
pressed and this expression pattern has been termed latency 
III. EBV-associated tumors demonstrate a third pattern of la-
tency-gene  expression  (latency  I/II)  in  which  only  EBNA-1 
and the BamHI-A rightward transcripts are expressed (latency 
I)  or  there  is  variable  expression  of  the  latency  membrane 
proteins LMP-1, LMP-2A, and LMP-2B in addition to EBNA-1 
and  the  BamHI-A  rightward  transcripts  (latency  II)  (2-4).
    Tumor  cells  in  virus-associated  tumors  express  viral  anti-T Lymphocytes Clonality in EBV-associated Gastric Carcinoma
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gens,  and  cytotoxic  T  lymphocytes  (CTLs)  responding  to 
these antigens destroy the tumor cells (5). CTLs responding 
to EBV-specific proteins are induced by EBV infection or re-
activation and these CTLs contribute to preventing EBV from 
p r o l i f e r a t i n g  w i t h i n  t h e  b o d y  ( 6 ) .  In  vitro C T L  c l o n a l  e x -
pansion for BARTs suggests that EBV antigens with weak anti-
genicity could also induce EBV antigen-specific cell-mediated 
immunity  (7).  However,  EBV  antigen-specific  cell-mediated 
immunity is prevented by either suppressing the expression 
of EBV antigens having strong antigenicity such as EBNA3A, 
and  EBNA3C  in  EBV-associated  tumors  or  self-inhibition  of 
translation  and  antigen  presentation  by  EBNA1  (8,9).
  I t  w a s  r e p o r t e d  t h a t  E B V  g e n o m e s  a r e  p r e s e n t  a n d  e x -
p r e s s e d  i n  p a t i e n t s  w i t h  g a s t r i c  c a r c i n o m a  ( 1 0 , 1 1 ) .  D e s p i t e  
the fact that only 6.9∼16% of all gastric cancer cases are EBV 
positive, EBV is detected in more than 85% of lymphoepithe-
lioma-like gastric carcinoma (LELC), in which lymphocyte in-
filtration is frequently seen (12,13). LELC whose lesions are 
mostly composed of lymphocytes is epithelial cell in origin 
but morphologically similar to lymphoma. LELC comprises 2% 
o f  a l l  g a s t r i c  c a n c e r  c a s e s  ( 1 4 )  B e c a u s e  t h e  p r o g n o s i s  f o r  
LELC is good and most infiltrating lymphocytes are CD8
＋ T 
cells (15), it can be speculated that EBV specific proteins ex-
pressed in LELC would act as the antigens to induce the ex-
pansion of specific CTLs and that cell-mediated response by 
proliferated  CTLs  would  affect  tumor  prognosis  (16).
    We investigated the expression of EBV genes in EBV-asso-
ciated gastric carcinoma tissues and the presence of clonally 
expanded infiltrating T lymphocytes in cancer tissues by de-
tecting the presence of the EBV genome and by measuring 
the TCR Vβ CDR3 usage in gastric cancer tissue samples ob-
tained from 30 patients. We found expression of EBNA1 and 
BARTs in 4 cases. By measuring the length of the TCR Vβ 
CDR3 gene of CD8
＋ T lymphocytes that have infiltrated into 
gastric cancer tissues and by conducting sequence analysis of 
these genes, we also found the possibility that the infiltrating 
lymphocytes EBV-associated gastric carcinomas resulted from 
the  clonally  expanded  CD8
＋  T  lymphocyte  population.
MATERIALS AND METHODS
Gastric carcinoma tissues and cell lines
We  examined  30  samples  of  primary  gastric  carcinoma  re-
sected from randomly selected Korean patients including 21 
males and 9 females whose ages ranged from 34∼76 years 
old. The positive and negative controls used for EBV gene 
expression were EBV positive B lymphoblastoid cell line and 
the  gastric  carcinoma  cell  line,  MKN45,  respectively.  Cells 
were cultured in RPMI 1640 medium (Gibco BRL) containing 
10% fetal bovine serum (Gibco BRL), 100 U/ml of penicillin 
and  100μg/ml  of  streptomycin  (Gibco  BRL).
EBV detection
DNA  PCR  was  performed  using  the  primers  SL18  (5’-GGC-
GCACCTGGAGGTGGTCC-3’)  and  SL19  (5’-TTTCCAGCAG-
AGTCGCTAGG-3’) to the variable number of tandem repeat 
(VNTR) in a mixture of 2μl of 5 mM dNTP, 1.25 U Taq poly-
merase (Perkin Elmer, Branchburg, NJ) and 10 pmol primer 
set. PCR was done in a thermal cycler (Perkin Elmer) by car-
rying out the reaction in 35 cycles of 30 sec at 94
oC, 30 sec 
at 55
oC, and 30 sec at 72
oC with 10 min. extension at 72
oC. 
The resulting PCR product was electrophoresed in 2% agarose 
gel and observed using an UV transilluminator after staining 
with  ethidium  bromide.
    EBV-encoded small nonpolyadenylated RNAs (EBERs) con-
stitutively expressed in EBV infected cells were used as the 
probe for in situ hybridization. Each of the 6μm tissue sam-
ples was placed on a sialine coated slide, left for 30 min at 
56
oC, and placed in xylene twice for 3 min each to remove 
paraffin. The tissue sample was then placed twice in 99% and 
95% ethyl alcohol solutions for 3 min each and hydrated by 
leaving the sample in distilled water. It was then reacted in 
Proteinase K (Sigma, St. Louis, MO) at 37
oC for 10 min, wash-
ed  in  distilled  water,  and  completely  dried  by  exposing  to 
air for 20 min. After 40∼100μl FITC-labeled EBERs probe 
(Dako, Denmark) was placed on the dried tissue sample, it 
was reacted at 37
oC for 2 h. The sample was placed in tris 
buffered saline (0.1 M Tris in normal saline; TBS) for 5 min 
and  washed  3  times  in  TBS  containing  0.1%  Triton  X-100. 
After  100μl  a n t i - F I T C  ( D a k o )  w a s  p l a c e d  o n t o  t h e  s a m p l e  
slide,  the  sample  was  reacted  for  30  min  at  room  temper-
ature,  washed  with  TBS,  reacted  with  alkaline  phospha-
tase-conjugated  anti-mouse Ig for 30 min,  and stained with 
BCIP/NBT.
    In order to determine the type of EBV, PCR was performed 
using EBNA3C specific primers (sense: 5’-AGAAGGGGAGCG-
TGTGTTGT-3’,  antisense:  5’-GGCTCGTTTTTGACGTCGGC- 
3’). The EBV type was determined based on the fact that type 
1 EBV would have an internal deletion at 93 bp, unlike type 
2 EBV, so the PCR product of type 1 EBV would be 153 bp, 
while  that  of  type  2  EBV  would  be  246  bp  (17).
    Reverse  transcriptase-polymerase  chain  reaction  (RT-PCR) T Lymphocytes Clonality in EBV-associated Gastric Carcinoma
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was performed to determine the expression of EBV specific 
genes in gastric cancer tissues. RNA was extracted using the 
RNeasy kit (Qiagen, Valencia, CA). A 30μl reaction mixture 
was  prepared  by  adding  5μg  RNA,  2μg  oligo-dT  primer 
(Pharmacia,  Uppsala,  Sweden),  2μl  10  mM  dNTP 
(Boehringer  Mannheim,  Mannheim,  Germany),  6μl 5× re-
verse transcriptase buffer, 200 U M-MLV reverse transcriptase 
(Gibco  BRL).  cDNA  was  synthesized  at  42
oC  for  60  min. 
R T - P C R  w a s  p e r f o r m e d  u s i n g  t h e  s y n t h e s i z e d  c D N A  a s  t h e 
template  and  the  primer  specific  for  each  gene  (18).
Immunohistochemistry
Immunohistochemistry  was  performed  using  anti-CD4,  an-
ti-CD8, and anti-CD20 antibodies to confirm the distribution 
of infiltrating T lymphocytes and B lymphocytes into gastric 
carcinoma in paraffin-embedded tissue sections. After leaving 
6μm of gastric carcinoma tissue sample on a sialine-coated 
slide, paraffin was removed. Add each primary antibody con-
jugated  to  alkaline  phosphatase  was  placed  onto  the  slide, 
the  sample  was  reacted  at  37
oC  for  1  h  and  stained  with 
BCIP/NBT. 
CDR3 length analysis
For TCR Vβ CDR3 RT-PCR, the β chain constant region (Cβ: 
5’-TTCTGATGGCTCAAACAC-3’)  was  used  as  the  antisense 
primer and a specific primer corresponding to each Vβ fam-
ily was used as the sense primer (19,20). PCR was performed 
using 4μl 1.25 mM dNTP, 1.25 U Taq polymerase (Perkin 
Elmer), and 10 pmol Vβ family specific primer and Cβ pri-
mer using cDNA synthesized from RNA extracted from gastric 
carcinoma  tissues.  PCR  was  performed  by  carrying  out  the 
reaction in 30 cycles of 30 sec at 94
oC, 30 sec at 55
oC, and 
30 sec at 72
oC, and extension was done at 72
oC for 10 min. 
After confirming the PCR product by electrophoresis in a 2% 
agarose gel, it was used as the nested-PCR template to de-
termine the TCR Vβ family. Nested-PCR was performed us-
ing 1μl TCR Vβ PCR product, 1 pmol sense Vβ primer, 
and 
32P-labelled antisense  Cβ primer.  After  electrophoresis 
of the PCR product in a sequencing gel, the gel was dried 
and exposed to Fuji Super HR-G X-ray film (Fuji Photo Film 
Co., Tokyo, Japan). The band intensity of each Vβ specific 
RT-PCR product was measured using the image plate and the 
predominant band was defined when the intensity of a single 
band was more than 1/3 of the total intensity. The predom-
inant bands considered to be specific T lymphocyte clonal ex-
pansion were cut and extract DNA. PCR was performed with 
the extracted DNA using the same Vβ primer and Cβ pri-
mer,  and  the  PCR  products  were  confirmed  using  electro-
phoresis in a 2% agarose gel. PCR products of DNA extracted 
from the gel were cloned in pT7Blue-T vector (Novagen, La 
Jolla, CA), and the nucleotide sequences were analyzed. At 
the same time, direct sequencing analysis was done using the 
PCR product by using the AmpliCycle sequencing kit (Perkin 
Elmer). The nucleotide sequences of at least 4 of the clones 
that were cloned into the pT7 Blue-T vector were analyzed. 
Clonal  expansion  of  a  specific  T  lymphocyte  was  defined 
when  the  clone  showing  the  same  result  as  the  direct  se-
quencing of the PCR product was present in more than 2/3 
of the total clones. The BLAST server by NCBI was used for 
Nucleotide  database  searching  and  computation.
RESULTS
Detection of the EBV genome in gastric carcinoma tis-
sue samples
PCR was performed using DNA extracted from gastric carci-
noma tissue samples to confirm the presence of the EBV ge-
nome  using  EBV  VNTR  specific  primers.  The  EBV  genome 
was  contained  in  gastric  tissue  samples  obtained  from  4 
(#967,  #974,  #1010,  and  #1016)  out  of  30  patients  (13.3%) 
(Fig. 1A). The fact that the VNTR PCR products of 4 tissue 
samples were seen as a single band (Fig. 1B) means that each 
case  of  gastric  carcinoma  was  infected  with  a  single  EBV 
clonotype. As for VNTR, each EBV strain could have a differ-
ent number of tandem repeats. Gastric carcinoma tissues with 
detected  EBV  genomes  were  undifferentiated adenocarcino-
mas according to H-E staining in which severe infiltration of 
lymphocytes  was  seen  around  the  gastric  carcinoma  cells 
(Fig. 2A). Two (#967, #1016) of the 4 samples with the EBV 
genome  were  confirmed  as  LELC.  According  to  the  EBV 
EBER-1 in situ hybridization results, EBV genomes were ob-
served in the nuclei of gastric carcinoma cells but not in the 
connective  tissues  and  infiltrating  lymphocytes  (Fig.  2B).
Types of EBV detected
T o  i n v e s t i g a t e  t h e  t y p e s  o f  E B V  i n f e c t i n g  g a s t r i c  c a r c i n o m a 
tissue samples with detectable EBV genomes, PCR was per-
formed  using  EBNA3C  specific  primers.  The  EBNA3C  gene 
shows  the  most  significant  difference  between  Type  1  and 
Type 2, in which an internal deletion is present in Type 1 
EBV (17). The PCR product of Type 1 EBV was153 bp, and 
that  of  Type 2 EBV  was 246  bp.  The  PCR results  from all T Lymphocytes Clonality in EBV-associated Gastric Carcinoma
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Figure 1. Detection of EBV DNA in gastric carcinoma tissues using
PCR. (A) DNA was extracted from 30 gastric carcinoma tissue 
samples, and PCR was performed using the EBV specific primers SL18
and SL19. PCR products were electrophoresed in a 2% agarose gel.
The EBV genome was detected in 4 of the samples (#967, #974, 
#1010, and #1016). No EBV genome was detected in the gastric 
carcinoma cell line, MKN45 (negative control), and 26 gastric 
carcinoma tissue samples. Lane 1: DNA size marker, 1 kb DNA 
ladder; MKN45: gastric carcinoma cell line showing no EBV infection;
967, 974, 1010, 1016: Gastric carcinoma tissues samples with the 
EBV genome. (B) VNTR DNA of EBV LMP1 was amplified and 
electrophoresis was performed. M: DNA size marker, 100 bp DNA
ladder; DW: distilled water; MKN45: gastric carcinoma cell line 
(negative control); LCL: B lymphoblastoid cell line (positive control) 
transformed with EBV produced with the B95.8 cell line; 967, 974, 
1010, 1016: gastric carcinoma tissue samples with EBV genes 
detected.
Figure 2. Pathological findings of gastric carcinoma tissue samples and EBER in situ hybridization. (A) The pathological findings of gastric carcinoma
tissue sample #967 containing the EBV genome. This carcinoma was an undifferentiated adenocarcinoma and shows severe infiltration of 
lymphocytes (H-E staining, ×400 magnification). (B) EBERs in situ hybridization. Nuclei of gastric carcinoma cells show a positive response, 
while lymphocytes infiltrating the gastric carcinoma tissues and the surrounding connective tissue show a negative response. 
Figure 3. Determination of EBV type in gastric carcinoma tissues. PCR
was performed using EBNA3C specific primers in order to determine
the type of EBV in gastric carcinoma tissues. The resulting PCR 
product was electrophoresed. Lane 1: DNA size marker, 100 bp DNA
ladder; MKN45: negative control; B95.8: positive control; 967, 974, 
1010, and 1016: gastric carcinoma tissue samples with EBV genes 
detected.
four samples showed the same size PCR product as that iso-
lated  from  the  B95.8  Type  1  EBV  (Fig.  3),  suggesting  that 
all  4  samples  were  infected  with  Type  1  EBV.
Expression of EBV gene in gastric carcinoma tissue 
samples
To  determine  the  type  of  latent  infection  present  in  gastric 
carcinoma  tissues,  which contain  the EBV  genome,  the ex-
pression profile of EBV latent genes was investigated using 
RT-PCR. EBNA1, which is the most important for the main-
tenance of the EBV episome, was expressed in all 4 samples. 
The EBNA1, which is the gene that is expressed in all types 
of  latent  infection  and  that  controls  DNA  replication  of  the 
EBV episome, was present in all samples. BARTs, which are 
usually  expressed  during  EBV  infection  was  detected  in  all 
4 samples. LMP2a was expressed in one sample (#967) out T Lymphocytes Clonality in EBV-associated Gastric Carcinoma
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Figure 4. Detection of EBV specific gene transcripts in gastric 
carcinoma tissue samples using RT-PCR. Total RNA was isolated from
gastric carcinoma tissues and cDNA was prepared. RT-PCR was 
performed using the cDNA as template and specific primers for EBV 
genes, i.e., EBNA1, EBNA2, BARTs and LMP-1. The resulting products
were electrophoresed in a 2% agarose gel. MKN45: negative control;
LCL: B lymphoblastoid cell line (positive control) transformed with 
EBV produced with the B95.8 cell line; 967, 974, 1010, 1016: gastric
carcinoma tissue samples with EBV gene detected. 
Figure 5. Distribution of lymphocytes infiltrating in gastric carcinoma tissues. Immunohistochemical staining of gastric carcinoma tissue #967
using anti-CD8 (A), anti-CD4 (B), and anti-CD20 (C) antibodies (200×).
of 4 samples. EBNA2 was not expressed in all 4 samples, sug-
gesting  that  the  C  and  W  promoters  were  not  activated. 
Because EBNA2, EBNA-LP, EBNA3A, EBNA3B, and EBNA3C 
expression  is  controlled  by  the  C  and  W  promoters,  they 
were not expressed, either. LMP-1, expressed during Type 2 
EBV  latent  infection,  was  not  expressed  (Fig.  4).
Distribution of infiltrating lymphocytes in gastric car-
cinoma tissues
Immunohistochemistry  was  performed  using  anti-CD4,  an-
ti-CD8 and anti-CD20 antibodies to investigate the distribution 
of lymphocytes infiltrating EBV-positive gastric carcinoma tis-
sue samples. Most lymphocytes were stained by anti-CD8 an-
tibodies (Fig. 5A) but not with anti-CD4 and anti-CD20 anti-
bodies (Fig. 5B and C), suggesting that most lymphocytes in-
filtrating  gastric  carcinoma  tissues  were  CD8
＋ T  c e l l s .
T cell clonality having specific TCR Vβ chain in CD8
＋ 
T cells infiltrating gastric carcinoma tissues 
Since  the  lymphocytes  infiltrating  gastric  carcinoma  tissues 
that  contain  the  EBV  genome  were  CD8
＋ T  l y m p h o c y t e s ,  
TCR Vβ chain usage was analyzed to determine the presence 
of  clonal  expansion  according  to  each  Vβ family  in  order 
to determine whether single clonal or oligoclonal T lympho-
cytes  recognizing  a  specific  antigen  were  expanded.  After 
performing RT-PCR with Vβ family specific primers, electro-
phoresis was done in a sequencing gel and CDR3 was sorted 
according to the different sizes (Fig. 6). After the band in-
tensity of each RT-PCR product was measured according to 
each Vβ family, the predominant band was defined when 
the intensity of a single band was more than 1/3 of the total 
intensity. The predominant band was observed in Vβ family 
2, 6 and 11 of T lymphocytes infiltrating sample #967; Vβ 
family  12  and  14  of  sample  #974;  Vβ family  3,  6,  8,  and 
15 in sample #1010; and in Vβ family 8 of sample #1016. 
DNA was extracted from a total of 10 predominant bands and 
its nucleotide sequence was determined by using PCR-direct T Lymphocytes Clonality in EBV-associated Gastric Carcinoma
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Figure 6. TCR Vβchain usage of DR3 of CD8
＋ T cells infiltrating gastric carcinoma tissues. After performing RT-PCR using specific primers
to each Vβ family, electrophoresis was done in a sequencing gel and CDR3 was divided according to sizes. The predominant band (arrow)
could be observed in Vβ family 2, 6, and 11 of sample #967; Vβ family 12 and 14 of sample #974; Vβ family 3, 6, 8, and 15 of sample 
#1010;Vβ family 8 of sample #1016. 967, 974, 1010, and 1016: Gastric carcinoma tissue samples with EBV gene detected.
Table I. Amino acid sequence and CDR3 length of TCR Vβ chain of CD8 T cells infiltrated to gastric carcinoma
Sequence CDR3 
length
Frequency of the 
same sequence 
among PCR clones VC D R 3 J C
#967
  Vβ2J β1.1 CS VFGFEMNTEAF FGQGTRLTVV EDLNKVFPP 9 4/4
  Vβ6J β2.3 CASS LGIAGPTDTQY FGPGTRLTVL EDLKNVFPP 11  8/11
  Vβ11 Jβ2.3 CASS GTSGTADTQY FGPGTRLTVL EDLKNVFPP 10 12/12
#974
  Vβ14 Jβ1.5 CAS RGTGWEYQPQH FGDGTRLSIL EDLNKVFPP 10 6/7
#1010
  Vβ8J β2.3 CASS RGGVDTQY FGPGTRLTVL EDLNKVFPP 8 3/4
sequencing and also by  cloning  the  PCR  product  with  pT7 
Blue-T vector at the same time. The two results were then 
compared. The nucleotide sequence of at least 4 clones that 
were cloned with pT7 Blue-T vector was analyzed. A specific 
T cell clone was expanded when the clone was more than 
2/3 of the total clones showing the same result as the direct 
sequencing of the PCR product. Among the selected predom-
inant bands, the nucleotide sequence obtained by direct se-
quencing was the same as the sequence obtained from the 
pT7 Blue-T vector with Vβ CDR3 cloned into it in all cases 
except for Vβ 12 of sample #974; Vβ 3, 6, and 15 of sample 
#1010;  and  Vβ 8  of  sample  #1016.  The  amino  acid  se-
quences deduced from these samples are shown in Table I. 
The length of CDR3 was determined by subtracting 4 amino 
acids from the number of amino acids present between the 
C-terminal  cysteine  in  the  Vβ region  and  the  first  glycine 
present  on  glycine/X/glycine  in  the  J  region.  The  CDR3 
l e n g t h  w a s  b e t w e e n  8  a n d  1 1 ,  f a l l i n g  i n  t h e  n o r m a l  r a n g e  
of TCR Vβ CDR3. Its average was 9.6, which is similar to 
9.5, the average  length of TCR  Vβ.  When  the Vβ family 
gene was searched using BLAST to confirm Jβ and C family, 
the  result  showed  3  clones  using  the  same  Jβ 2.3  TCR. T Lymphocytes Clonality in EBV-associated Gastric Carcinoma
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Arginine was synthesized by N-addition in the V-D region of 
TCR Vβ of T lymphocytes infiltrating gastric carcinoma tissue 
samples  #974  and  #1010.
DISCUSSION
G a s t r i c  c a r c i n o m a  i s  o n e  o f  t h e  m o s t  p r e v a l e n t  c a r c i n o m a s  
in the world and is the most frequent carcinoma in Far East 
Asian countries such as Korea and Japan. Many studies re-
ported various indirect evidences that EBV plays an important 
r o l e  i n  E B V - a s s o c i a t e d  g a s t r i c  c a r c i n o m a  ( 2 1 , 2 2 ) .  F u r t h e r -
more,  EBV-associated  gastric  carcinoma,  which  has  a  good 
prognosis, shows some p53 mutations, which are frequently 
seen in stomach cancer (23), and severe infiltration of lym-
phocytes  into  tumor  tissues  (16,24).  According  to  previous 
studies, EBV is crucial for malignant transformation in EBV-as-
sociated gastric carcinoma (25). At the same time, we could 
assume that EBV would enable the T lymphocytes of the host 
t o  r e c o g n i z e  t r a n s f o r m e d  t u m o r  c e l l s .  T h e r e f o r e ,  w e  d e -
termined  the  presence  of  EBV  specific  gene  expression  in 
EBV-associated gastric carcinoma and lymphocytes infiltrating 
into  the  tumor  cells  were  clonal  expansions  of  CD8
＋ T  
lymphocytes.
    EBV-associated gastric carcinoma accounts for 6.9∼16% of 
al l c as es  o f g a st ric  c ar ci no m a ( 10 ).  W e  f ou n d th e  E BV  g e-
nome in 4 (13.3%) of the 30 gastric carcinoma tissues sam-
ples. According to another study  investigating the presence 
of  the  EBV  genome  in  gastric  carcinoma  cases  among 
Koreans, the EBV genome was detected in 13.5% of all gastric 
carcinoma cases (26). We found similar result in this study. 
According to histopathologic findings of gastric carcinoma tis-
s u e  s a m p l e s  c o n t a i n i n g  t h e  E B V  g e n o m e ,  t h e  t i s s u e s  w e r e  
poorly differentiated and were severely infiltrated with lym-
phocytes. According to EBERs in situ hybridization, no EBV 
genome was detected in the surrounding lymphocytes. Thus, 
these results indicate that EBV was present in gastric carcino-
ma cells rather than in infected lymphocytes that infiltrated 
the gastric carcinoma. EBV can be largely divided into two 
types (Type 1 and Type 2), which have a slightly different 
gene composition (17). The distribution of these two types 
is similar in healthy individuals. However, most of the EBV 
isolated from tumors is Type 1, so that Type 1 EBV is more 
involved in tumorigenesis compared with Type 2 (27). EBV 
detected  in  all  4  samples  in  this  study  was  also  Type  1.
    EBV  is  associated  with  many  tumors  and  latent  infection 
could  be  divided  into  3  different  types  classified  according 
to the specific genes expressed in the tumor cells (2). The 
expression of EBNA1, LMP-2 and BARTs were previously re-
ported in EBV-associated gastric carcinoma (28). In this study, 
we observed the expression of only EBNA1, LMP-2 (1/4) and 
BARTs and no expression of EBN A2, suggesting that the C 
and W promoters are not activated. Furthermore, we did not 
observe the expression of LMP-1. Although EBNA1 expressed 
in Type 1 latent infection is expected to play an essential role 
in malignant cell transformation, the mechanism involved in 
this  process  has  not  been  elucidated.
    According to immunohistochemistry and sequence analysis 
of the TCR Vβchain of CDR3, we found that there was an 
expansion  of  5  specific  T  lymphocyte  clones.  It  was  likely 
that these clones were expanded tumor-specific CD8
＋ T lym-
phocytes, suggesting that tumor specific antigens are present 
i n  E B V - a s s o c i a t e d  g a s t r i c  c a r c i n o m a  a n d  t h a t  C D 8
＋ T  l y m-
phocytes responding to these antigens have infiltrated tumor 
tissues.  Thus,  the  good  prognosis  of  EBV-associated  gastric 
carcinomas could be accounted for by these CD8
＋ T lympho-
cytes that result in tumor-specific cytotoxicity. The fact that 
we could not observe the same TCR clonal expansion in 3 
samples suggests that CD8
＋ T lymphocyte clonal expansion 
did not respond to superantigens. This is in contrast to results 
reported  previously  that  lytic  cycle  specific  proteins  would 
function  as  superantigens  to expand CTL clone at the time 
of  primary EBV  infection  (29).  We observed  various  CD8
＋ 
T  lymphocyte  clonal  expansions  possibly  because  antigens 
expressed  during  latent  infection  are  conventional  antigens 
and  specific  CD8
＋  T  lymphocytes  would  recognize  various 
antigenic  peptides  originating  from  EBV  proteins  that  form 
c o m p l e x e s  w i t h  M H C  c l a s s  I  m o l e c u l e s .  I n  t h i s  s t u d y ,  w e  
found  that  CD8
＋  T  lymphocytes  infiltrated  EBV-associated 
gastric carcinoma cells and  that  EBNA1,  LMP2a and  BARTs 
were expressed. This suggests that EBNA1, LMP2, or BARTs 
could  provide  the  antigens  that  result  in  the  expansion  of 
CD8
＋ T lymphocytes. Since EBNA1 has the Gly-Ala rich do-
m a i n  t h a t  p r e v e n t s  a n t i g e n  p rocessing  and  presentation, 
EBNA1  is  not  immunogenic  to  Human  CD8
＋ T  c e l l  ( 3 0 ) .  
However,  it  was  reported  that  Human  CD4
＋ T  c e l l s  c o n -
sistently respond to the EBNA1, and BARTs LMP2a could act 
as  an  antigenic  determinant  in  NPC  and  HD  (7,31,32).
    We detected the presence of the EBV genome, specifically 
Type 1 EBV, in gastric carcinoma tissues. We observed the 
expression of EBNA1, LMP2a and BARTs in gastric carcinoma 
tissue samples that have the EBV genome but found no ex-
pression of EBNA2 and LMP-1. We found that lymphocytes T Lymphocytes Clonality in EBV-associated Gastric Carcinoma
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infiltrating in gastric carcinoma tissues in EBV-associated gas-
tric carcinoma were CD8
＋ T lymphocyte clones responding 
to  specific  conventional  antigens.  We  determined  this  by 
measuring the length and analyzing the nucleotide sequence 
of TCR Vβ CDR3 of T lymphocytes that have infiltrated gas-
tric carcinoma tissues. This result suggests that EBV-specific 
proteins act as antigens in EBV-associated gastric carcinoma 
to induce a cell-mediated immune response. Further in vitro 
CTL  proliferation  studies  using  EBV-specific  proteins  are 
needed  to  determine  specific  epitopes.
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